The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tereshchenko G.P.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia;
Peoples’ Friendship University of Russia, Moscow, Russia

Gadzhigoroeva A.G.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia;
Peoples’ Friendship University of Russia, Moscow, Russia

Zhukova O.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia;
Peoples’ Friendship University of Russia, Moscow, Russia

Novozhilova O.L.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Tolstoguzova E.V.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Berezovskaya E.M.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Vurdov D.Yu.

«Central Scientific Research Institute for Healthcare Organization and Informatization» of the Ministry of Health of the Russian Federation, Moscow, Russia

Piterskaya E.P.

Endocrinology Research Centre, Moscow, Russia

Golousenko I.Yu.

Russian University of Medicine, Moscow, Russia

Alopecia areata morbidity structure considering the association with atopic dermatitis in the population of Moscow in comparison with data from the federal register

Authors:

Tereshchenko G.P., Gadzhigoroeva A.G., Zhukova O.V., Novozhilova O.L., Tolstoguzova E.V., Berezovskaya E.M., Vurdov D.Yu., Piterskaya E.P., Golousenko I.Yu.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2026;25(2): 169‑177

DOI: 10.17116/klinderma202625021169

Read: 287 times

Contact the author
Table of contents

ALOPECIA AREATA MORBIDITY STRUCTURE CONSIDERING THE ASSOCIATION WITH ATOPIC DERMATITIS IN THE POPULATION OF MOSCOW IN COMPARISON WITH DATA FROM THE FEDERAL REGISTER
ALOPECIA AREATA MORBIDITY STRUCTURE CONSIDERING THE ASSOCIATION WITH ATOPIC DERMATITIS IN THE POPULATION OF MOSCOW IN COMPARISON WITH DATA FROM THE FEDERAL REGISTER

To cite this article:

Tereshchenko GP, Gadzhigoroeva AG, Zhukova OV, et al. Alopecia areata morbidity structure considering the association with atopic dermatitis in the population of Moscow in comparison with data from the federal register. Russian Journal of Clinical Dermatology and Venereology. 2026;25(2):169‑177. (In Russ.)
https://doi.org/10.17116/klinderma202625021169

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Gene­sis of emollients. Past, present, future. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):412-420
From atopy to infe­ction — a clinical case of combined skin pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):430-436
Atopic dermatitis: the problem of adhe­rence to emollients. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):698-707
Issues of diagnosis and treatment of atopic dermatitis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):838-845
Asse­ssment of psychological trauma in patients with atopic dermatitis. Russian Journal of Clinical Dermatology and Vene­reology. 2026;(1):47-52
Mechanisms of addi­tivity of physiotherapeutic factors in complex therapy of poly­pous rhinosinusitis complicated by como­rbidities. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):5-11
Sleep diso­rders and the course of atopic dermatitis in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(5-2):105-109
Features of the microbial landscape of the skin of patients with atopic dermatitis during exacerbation and in the remi­ssion phase. Journal of Adaptive Medi­cal Immu­nology and Public Health Issues. 2026;(1):60-66
Stress as an inte­rdisciplinary problem in the clinic of immuno-dependent diseases. Journal of Adaptive Medi­cal Immu­nology and Public Health Issues. 2026;(1):71-77
Abstract:

BACKGROUND

Alopecia areata (AA) is an autoimmune disease in which association with atopic dermatitis (AD) is one of the prognostically adverse factors. The relevance of studying the structure of AA morbidity taking into account atopic comorbidity is caused by the lack of modern epidemiological data and age differences in clinical manifestations.

OBJECTIVE

To study the structure of AA morbidity in the population of Moscow and the federal register with emphasis on association with AD.

MATERIAL AND METHODS

A multicenter retrospective cohort study was carried out on the basis of data from the Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology (MSPCDC) and the register of adult patients with AA for 2020—2024. The analysis included stratification according to ICD-10 (L63.0—L63.8), age groups (children aged 0—17 years and adults aged 18 years and older), assessment of association with AD (L20.8), calculation of extensive and intensive indicators (per 100 000 population). Methods of descriptive and analytical statistics were used: logistic regression, χ² and Mann—Whitney U tests, Bonferroni correction.

RESULTS

Prevalence of local forms (L63.8—84.9%) with a steady increase in their proportion (+3.2 p.p., p<0.001) especially among children (+8.6 p.p.) was revealed. Severe forms (L63.0—L63.2) amounted to 15.1%, more frequently occurring in children (15.2% versus 12.6%, p<0.05), especially ophiasis (1.7 times more frequent, p=0.013). Association with AD was noted in 2.7% of patients with maximum increase in children (+2.2 p.p., p=0.013). For comorbidity with AD, alopecia totalis (18.2% versus 8.1% in the overall group, OR 2.47, p<0.001) and universalis (7.4% versus 3.0%, OR 2.41, p=0.003) predominated. In the register (n=403), AD was diagnosed in 15.9% of patients predominantly with alopecia universalis (27.9%, OR 4.2, p<0.001).

CONCLUSION

The significant association of severe forms of AA with AD emphasizes the importance of considering the atopic background in assessing the clinical course of alopecia.

Keywords:

alopecia areata
alopecia totalis
alopecia universalis
ophiasis
atopic dermatitis
association

Authors:

Tereshchenko G.P.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia;
Peoples’ Friendship University of Russia, Moscow, Russia

Gadzhigoroeva A.G.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia;
Peoples’ Friendship University of Russia, Moscow, Russia

Zhukova O.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia;
Peoples’ Friendship University of Russia, Moscow, Russia

Novozhilova O.L.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Tolstoguzova E.V.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Berezovskaya E.M.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Vurdov D.Yu.

«Central Scientific Research Institute for Healthcare Organization and Informatization» of the Ministry of Health of the Russian Federation, Moscow, Russia

Piterskaya E.P.

Endocrinology Research Centre, Moscow, Russia

Golousenko I.Yu.

Russian University of Medicine, Moscow, Russia

Received:

28.08.2025

Accepted:

13.01.2026

Close metadata

References:

  1. Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U. Alopecia areata — Current understanding and management. J Dtsch Dermatol Ges. 2022 Jan;20(1):59-90.  https://doi.org/10.1111/ddg.14689
  2. Trüeb RM, Dutra H, Dias MFRG. A Comment on JAK Inhibitors for Treatment of Alopecia Areata. Int J Trichology. 2018 Sep-Oct;10(5):193-197.  https://doi.org/10.4103/ijt.ijt_62_18
  3. Ramos PM, Anzai A, Duque-Estrada B, Melo DF, Sternberg F, Santos LDN, Alves LD, Mulinari-Brenner F. Consensus on the treatment of alopecia areata — Brazilian Society of Dermatology. An Bras Dermatol. 2020 Nov-Dec;95(1):39-52.  https://doi.org/10.1016/j.abd.2020.05.006
  4. Rudnicka L, Trzeciak M, Alpsoy E, et al. Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel. Front Med (Lausanne). 2024 Apr 22;11:1353354. https://doi.org/10.3389/fmed.2024.1353354
  5. Vañó-Galván S, Blume-Peytavi U, Farrant P, et al. Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries. Dermatol Ther (Heidelb). 2023 Dec;13(12):3121-3135. https://doi.org/10.1007/s13555-023-01057-0
  6. Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018 Jan; 78(1):1-12.  https://doi.org/10.1016/j.jaad.2017.04.1141
  7. Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options. Int J Trichology. 2018 Mar-Apr;10(2):51-60.  https://doi.org/10.4103/ijt.ijt_99_17
  8. Krzeszowska P, Kujawa A, Krochmal K, Pisarek W, Samoraj A, Zajączkowski J, Stępniak K, Wilk J, Marrodán-Wojtczak K, Kuźma R. Jak inhibitors in the treatment of alopecia areata — a literature review. Journal of Education, Health and Sport. 2025;82:60104. https://doi.org/10.12775/JEHS.2025.82.60104
  9. Biran R, Zlotogorski A, Ramot Y. The genetics of alopecia areata: new approaches, new findings, new treatments. J Dermatol Sci. 2015 Apr;78(1):11-20.  https://doi.org/10.1016/j.jdermsci.2015.01.004
  10. Zhou W, Cai J, Li Z, Lin Y. Association of atopic dermatitis with autoimmune diseases: A bidirectional and multivariable two-sample mendelian randomization study. Front Immunol. 2023 Mar 30;14:1132719. https://doi.org/10.3389/fimmu.2023.1132719
  11. Kridin K, Renert-Yuval Y, Guttman-Yassky E, Cohen AD. Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients. J Allergy Clin Immunol Pract. 2020 Apr;8(4):1323-1328.e1.  https://doi.org/10.1016/j.jaip.2020.01.052
  12. Lee NR, Kim BK, Yoon NY, Lee SY, Ahn SY, Lee WS. Differences in Comorbidity Profiles between Early-Onset and Late-Onset Alopecia Areata Patients: A Retrospective Study of 871 Korean Patients. Ann Dermatol. 2014 Dec;26(6):722-726.  https://doi.org/10.5021/ad.2014.26.6.722
  13. Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011 Nov;65(5):949-956.  https://doi.org/10.1016/j.jaad.2010.08.032
  14. Mohan GC, Silverberg JI. Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis. JAMA Dermatol. 2015 May;151(5):522-528.  https://doi.org/10.1001/jamadermatol.2014.3324
  15. Gadzhigoroeva AG, Potekaev NN. Lechenie patsientov s gnezdnoi alopetsiei s uchetom stepeni aktivnosti protsessa i ploshchadi poteri volos: metodicheskie rekomendatsii. M.: GBUZ Mosk. nauch.-prakt. tsentr dermatovenerologii i kosmetologii Dep. zdravookhraneniya g. Moskvy; 2019. Accessed July 8, 2025. (In Russ.). https://mosderm.ru/upload/pages/method_rec/5e41c4f616f7.pdf
  16. Lavian J, Li SJ, Lee EY, Bordone LA, Polubriaginof FCG, Christiano AM, Mostaghimi A. Validation of Case Identification for Alopecia Areata Using International Classification of Diseases Coding. Int J Trichology. 2020 Sep-Oct;12(5):234-237.  https://doi.org/10.4103/ijt.ijt_67_20
  17. Mostaghimi A, Gao W, Ray M, Bartolome L, Wang T, Carley C, Done N, Swallow E. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population. JAMA Dermatol. 2023 Apr 1; 159(4):411-418.  https://doi.org/10.1001/jamadermatol.2023.0002
  18. Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. J Am Acad Dermatol. 2020 Mar;82(3):675-682.  https://doi.org/10.1016/j.jaad.2019.08.032
  19. Sibbald C. Alopecia Areata: An Updated Review for 2023. J Cutan Med Surg. 2023 May-Jun;27(3):241-259.  https://doi.org/10.1177/12034754231168839
  20. Tereshchenko GP, Potekaev NN, Gadzhigoroeva AG, Zhukova OV, Golousenko IYu. Clinical and epidemiological features of atopic type of alopecia areata. Russian Journal of Clinical Dermatology and Venereology. 2024; 23(2):155-160. (In Russ.). https://doi.org/10.17116/klinderma202423021155
  21. Lim CP, Severin RK, Petukhova L. Big data reveal insights into alopecia areata comorbidities. J Invest Dermatol Symp Proc. 2018;19:57-61.  https://doi.org/10.1016/j.jisp.2017.10.006
  22. Kageyama R, Ito T, Hanai S, Morishita N, Nakazawa S, Fujiyama T, Honda T, Tokura Y. Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata. International Journal of Molecular Sciences. 2021;22(5):2618. https://doi.org/10.3390/ijms22052618
  23. Petrova SYu, Albanova VI. Alopecia areata in atopic dermatitis: coincidence or regularity? Russian Medical Inquiry. 2022;6(2):85-91. (In Russ.). https://doi.org/10.32364/2587-6821-2022-6-2-85-91
  24. Pellefigues C. IgE Autoreactivity in Atopic Dermatitis: Paving the Road for Autoimmune Diseases? Antibodies (Basel). 2020 Sep 8;9(3):47.  https://doi.org/10.3390/antib9030047
  25. Lee HJ, Hong NS, Kim SH, Jang YH. Association between Alopecia Areata and Comorbid Allergies: Implications for Its Clinical Course. Ann Dermatol. 2020 Dec;32(6):523-525.  https://doi.org/10.5021/ad.2020.32.6.523
  26. Friedrich A, Schmitz MT, Gossmann Y, Redler S, Blaumeiser B, Lutz G, Blume-Peytavi U, Nöthen MM, Betz RC, Basmanav FB. Comorbid Bronchial Asthma, Atopic Dermatitis and Hashimoto’s Thyroiditis Are Risk Factors for Early-Onset, Severe and Prolonged Alopecia Areata. Allergy. 2025 Apr;80(4):1158-1161. https://doi.org/10.1111/all.16468
  27. Harries M, Al-Nuaimi Y, Wall D, Chandidzura A, Ahmed S, Meah N. The Global Register of Alopecia areata disease Severity and treatment Safety — United Kingdom (GRASS-UK): importance of real-world data in alopecia areata. Clin Exp Dermatol. 2025 May 23;50(6):1250-1252. https://doi.org/10.1093/ced/llaf055
  28. Holmes S, Harries M, Macbeth AE, Chiu WS, de Lusignan S, Messenger AG, Tziotzios C. Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study. Clin Exp Dermatol. 2023 Mar 22;48(4):325-331.  https://doi.org/10.1093/ced/llac104
  29. Chen W, Li S, Cai X, Wang C, Wang S, Huang K, Chen Y, Li X. Association between alopecia areata and atopic dermatitis: Current evidence. J Eur Acad Dermatol Venereol. 2023 Mar 13;37(8):e980-e984. https://doi.org/10.1111/jdv.19044
  30. Waśkiel-Burnat A, Osińska M, Salińska A, Blicharz L, Goldust M, Olszewska M, Rudnicka L. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications. Cells. 2021 Dec 2;10(12):3397. https://doi.org/10.3390/cells10123397
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.